Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1 Klatskin Tumor 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 6 Cisplatin 6 Capecitabine 6 Liver Transplantation 4 Fluorouracil 4 Specimen Handling 3 Radiosurgery 3 Oxaliplatin 3 Magnetic Resonance Spectroscopy 3 toripalimab 2 dehydroftorafur 2 Self Expandable Metallic Stents 2 Platinum 2 Leucovorin 2 Biopsy 2 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 2 1,2-diaminocyclohexaneplatinum II citrate 2 trisacryl gelatin microspheres 1 tremelimumab 1 trametinib 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 ricolinostat 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 durvalumab 1 binimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Klatskin Tumor × Pancreatic Hormones × Gastrointestinal × Clear all

NCT06850753 2025-08-21

SURE-LT

Oslo University Hospital

Phase NA Recruiting

Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡